Unexplained Sudden Cardiac Death in Saudi Arabia presentation2011/008005.pdf · Klinische Genetica...
Transcript of Unexplained Sudden Cardiac Death in Saudi Arabia presentation2011/008005.pdf · Klinische Genetica...
Klinische Genetica
Sudden Unexplained DeathBoy: 1 yearGirl: 1 and ½ yearGirl: 16 yearBoy: 26 yearBoy: 16 year
Klinische Genetica
Family A:
VI:1: Sudden Death at 10 yrs, drowningVI:2: Sudden death at 5 yrs.VI:4: 3yrs, Aborted Sudden Cardiac ArrestVI:5: Sudden death at 12 yrs
Family B:
II:1: Sudden Death at 2 yrs with ConvulsionII:4: 14 yrs, Aborted Sudden Cardiac Arrest
I:1 I:2
II:1 II:2 II:3
III:1
II:4
III:2 III:3 III:4 III:5 III:6
IV:1 IV:2
V:1
V:2
V:3
V:4
VI:1 VI:2 VI:3 VI:4 VI:5
Family A
Family A and B: Referred by Dr. Tarek Momenah, PSCC
Family B
I:1 I:2
II:2II:1 II:3 II:4 II:5 II:6
Klinische Genetica
DSG2
DSG2
DSC2
DSC2PKP2
PKP2 JUP
JUP
DSPDSP
Heart at the Cellular Level
P
Q
T
R
S
Function of the Heart
Sino-atrial nodeAtrio-ventricular node
Left atrium
Right atrium
Right Ventricle Left Ventricle
Klinische Genetica
• Long QT Syndrome• Brugada Syndrome• Catecholamine-induced PMVT/VF• Short QT Syndrome• Isolated Cardiac Conduction Disorders • Familial Atrial Fibrillation• Sinus Node Disease, Atrial Standstill• Arrhythmogenic Right Ventricular Dysplasia/
Cardiomypathy
Cardiac Arrhythmia Syndromes
Klinische Genetica
Family A:
VI:1: Sudden Death at 10 yrs, drowningVI:2: Sudden death at 5 yrs.VI:4: 3yrs, Aborted Sudden Cardiac ArrestVI:5: Sudden death at 12 yrs
Family B:
II:1: Sudden Death at 2 yrs with ConvulsionII:4: 14 yrs, Aborted Sudden Cardiac Arrest
I:1 I:2
II:1 II:2 II:3
III:1
II:4
III:2 III:3 III:4 III:5 III:6
IV:1 IV:2
V:1
V:2
V:3
V:4
VI:1 VI:2 VI:3 VI:4 VI:5
Family A
Family A and B: Referred by Dr. Tarek Momenah, PSCC
Family B
I:1 I:2
II:2II:1 II:3 II:4 II:5 II:6
Klinische Genetica
Clinical Phenotypes
Triggering Factor
Family History
ECG Phenotypes
Investigation of Familial Cardiac Arrhythmia Syndromes
Klinische Genetica
Father
Mother
Child with History of Unconsciousness
ECG of Family Members with History of Sudden Unexplained Death
HealthySon
Klinische Genetica
Father
Mother
HealthySon Child with History of Unconsciousness
ECG of Family Members with History of Sudden Unexplained Death
Klinische Genetica
GTCTAGCAGCTTCCT
Patients
T>A (homozygous) Exon 2
GTCT T GCAGCTTCCT
Heterozygous carriers
T>A (heterozygous) Exon 2
DNA Analysis: KCNQ1 Gene
Klinische Genetica
1 1g gc c2 31 21 1
Family B
I:1 I:2
II:2II:1 II:3 II:4 II:5 II:6
I:1
I:2
II:1 II:2 II:3
III:1
II:4
III:2
III:3
III:4
III:5
III:6
IV:1
IV:2
V:1 V:2 V:3
V:4
VI:1
VI:2
VI:3
VI:4
VI:5
D11S4046(KCNQ1) Exon 13(KCNQ1) Exon 16D11S1338D11S902
D11S4046(KCNQ1) Exon 13(KCNQ1) Exon 16D11S1338D11S902
2 1a gc c3 13 2
2 1a gc t3 13 1
1 1g gc t1 12 1
3 1a gc t2 11 1
Family A
Arrhythmia Causing Founder Mutation in Assir
Klinische Genetica
N.H
Courtesy of Dr. Safar Al-Shahrani, Khamis Mashayt Military Hospital
N. H
Arrhythmia Causing Founder Mutation in Assir
Klinische Genetica
c.387 -5T>A in KCNQ1 gene is an Ancestral Founder Mutation in Assir Region of Saudi Arabia: Responsible for Cardiac Arrhythmia
Quite significant number of people from Assir region Carry this mutation.
Klinische Genetica
AAGGGGAGACTCTGCTGACACCC AAGGGGAGACTGCTGACACCC
AAGGGGAGACT………………… AAGGGGAGACT…………………
Control Patient
Father Mother
Genetic Analysis
Klinische Genetica
AAGGGGAGACTCTGCTGACACCC AAGGGGAGACTGCTGACACCC
AAGGGGAGACT………………… AAGGGGAGACT…………………
Control Patient
Father Mother
Genetic Analysis
Klinische Genetica
c.1486_1487delCT in KCNQ1 gene is MOST LIKELY an Ancestral Founder Mutation in
Al Baha region of Saudi Arabia: Responsible for Cardiac Arrhythmia
Klinische Genetica
Patient from Madinah
TGGGCCTCATCTTCTCCTCGTAC TGGGCCTC…………………………
TGTGGTGGTGATGAGCCCAC TGTGGTGGTGATGAGCCCAC
Control Patient
Control Patient
Klinische Genetica
Sudden Unexplained DeathBoy: 1 yearGirl: 1 and ½ yearGirl: 16 yearBoy: 26 yearBoy: 16 year
Klinische Genetica
1168-TCCACCTGGAAGATCTACATC390- S T W K I Y I
1168-TCCACCTGGAATATCTACATC390- S T W N I Y I
Screening of the KCNQ1 Gene
Klinische Genetica
1168-TCCACCTGGAAGATCTACATC390- S T W K I Y I
1168-TCCACCTGGAATATCTACATC390- S T W N I Y I
Heterozygous G>T Homozygous G>T
Screening of the KCNQ1 Gene
Klinische Genetica
miscarriage,8th week
Mis-carriage,10th week
Still birth, 29th week
I:1 I:2
II:1 II:2 II:3 II:4 II:5 II:6 II:7
320 314155 14385 71336 332
320 320151 15585 85
334 336
320 320155 15585 85
332 336
320 320155 15585 85336 336
D7S661D7S636D7S798D7S2465
D7S661D7S636D7S798D7S2465
Patient from Assir
22nd week: bradycardia23-24th week:bradycardia/tachyarrhythmiastill birth: 29th week
22nd week: bradycardia24th week:bradycardia/tachyarrhythmia
Klinische Genetica
c.3208 C>T in KCNH2 gene is an Ancestral Founder Mutation in Assir Region of Saudi Arabia: Responsible for Cardiac Arrhythmia
Klinische Genetica
Conclusions from the Study
►Role of Genetics is Crucial in Cardiac Arrhythmia and/orSudden Cardiac Death.
► We have identified several ancestral founder mutations inSaudi Arabia, which are NOT UNCOMMON.
► Timely identification of the Genetic Aetiology will lead toproper preventive and as well curative measures.
► Genetic Investigation should always be considered in patientmanagement.
Klinische Genetica
Princess Al-Jawhara Center of Excellence in Research of Hereditary Disorders
King Abdulaziz University, Medical School, JeddahTel: 0264020000 Ext# 21053 or 20115Fax: 0264020000 Ext # 20115 or 20519
E. mail: [email protected]
Clinical Genetic Investigation of Arrhythmia
Klinische Genetica
Acknowledgments
▶Dr. Tarek Momenah, PSCC, Riyadh
▶Prof. Dr. Arthur Wilde, Amsterdam University
▶Dr. Saleh Al-Ghamdi, PSCC, Riyadh
▶Dr. Jumana Al-Aama, PACER-HD, Jeddah
▶Dr. Safar Al-Shahrani, Khamis Mashayt Military Hospital
▶Ms. Khalda Nasser, Ms. Alaa Qarawi, PACER-HD, Jeddah.
▶King Abdulaziz City for Science & Technology
Klinische Genetica
Conclusions from the Study
• c.387 -5 T>A (KCNQ1) is a LQT, type 1 causing Founder mutation in Saudi Arabia.
• Biallelic/Homozygous carriers are highly susceptible to Fatal Arrhythmias and Sudden Death (but no Deafness).
• Monoallelic carriers for this mutation are unlikely to suffer from LQT1 mediated arrhythmia.
• Cascade screening is strongly recommended in this community for this mutation as β–blockers could effectively protect the carriers from unexpected sudden deaths.